India’s Generic Semaglutide Market Poised to Explode as Patent Expires, Slashing Weight-Loss Drug Prices by Half
India could soon expand access to weight-loss drugs dramatically as the patent on semaglutide, the molecule behind Novo Nordisk's blockbuster ...
